Haloperidol Richter

Haloperidol Richter is a prescription medication that contains the active ingredient haloperidol. The product is supplied in an oral dosage form, with strength not specified in the available information. It belongs to the butyrophenone class of antipsychotics and is marketed in the European Union. Haloperidol works primarily as a dopamine D2 receptor antagonist and is used under medical supervision for certain psychiatric conditions.

Haloperidol Richter is indicated for several psychiatric and neurological conditions where dopamine blockade is beneficial.

- Management of schizophrenia in adults. - Treatment of acute psychotic episodes. - Control of severe agitation associated with psychiatric disorders. - Adjunct therapy for Tourette syndrome. - Short‑term use in patients with severe behavioral disturbances. - May be employed in other off‑label situations as determined by a healthcare professional.

Side effects of haloperidol can vary in frequency and severity. Patients should be aware of both common and serious reactions.

Common: - Drowsiness or sedation. - Extrapyramidal symptoms such as tremor or rigidity. - Dry mouth. - Constipation. - Blurred vision. - Weight gain.

Serious: - Tardive dyskinesia (involuntary movements). - Neuroleptic malignant syndrome (fever, muscle rigidity). - Severe hypotension. - Cardiac arrhythmias (QT prolongation). - Elevated prolactin levels causing hormonal changes. - Seizures in predisposed individuals.

Before initiating Haloperidol Richter, clinicians should evaluate several safety considerations.

- Assess cardiovascular status, especially for QT interval prolongation. - Monitor for signs of extrapyramidal symptoms and tardive dyskinesia. - Use caution in patients with a history of seizures or epilepsy. - Evaluate liver and renal function for dose adjustments. - Discuss potential hormonal effects, such as hyperprolactinemia, with patients. - Review any history of neuroleptic malignant syndrome. - Consider pregnancy and lactation status; use only if benefits outweigh risks.

Haloperidol can interact with various medications, influencing its efficacy and safety profile.

Avoid: - Other dopamine antagonists that may increase extrapyramidal risk. - Medications that prolong the QT interval (e.g., certain antiarrhythmics, macrolide antibiotics). - Strong CYP3A4 inhibitors that can raise haloperidol plasma levels.

Use with caution: - CNS depressants such as benzodiazepines or opioids, which may enhance sedation. - Anticholinergic agents that can mask extrapyramidal symptoms. - CYP2D6 substrates, as haloperidol may affect their metabolism. - Lithium, due to potential additive neurotoxic effects. - Alcohol, which can increase central nervous system depression.